Accountable for leading the L&D organization in support of Merck Vaccine Operations' training compliance, employee capability builds, and learning innovations. Drive employee time-to-competency, retention, productivity, and cost efficiency KPIs to maximize the business impact of human capital.Lead the strategic initiatives related to employee inclusion and diversity, managerial and leadership acumen, and career development.Executive Sponsor for the West Point DE&I Council and Asia Pacific Association EBRG.

Responsible for cultivating AstraZeneca's strategic partnerships in the BioHealth Capital Region (MD-DC-VA) and national R&D hubs (BOS, SF, NYC) to accelerate the growth of the public-private-academe ecosystem; representing (R&D + Ops) on the many government, educational and industry-peer boards and committees to provide thought leadership that advances AstraZeneca's strategic objectives.Owner of AstraZeneca's national STEM programming to inspire the next generation of scientists and engineers through outreach and partnerships. 1M+ K-12 STEM students in 100+ countries impacted through digital and hands-on experiential learning activities. Partnered to secure $5M in federal and state funding to support STEM-to-Industry talent pipeline development.

Accountable for the strategic business unit comprised of Training & Education, Training Systems Capability and Talent & Organization Effectiveness.Achieved annual cost savings amounting to 80% budget ROI, shifting the enabling function from an overhead cost to a profit margin input.Established governance and standards for the L&D business process to support our fully commercial manufacturing site. 5%+ process maturity growth YOY.Successful global regulatory defense of Training Program and LMS in support of (3) commercial product launches and multiple pre-approval clinical products.Demonstrated ability to effectively lead during periods of expansion and contraction utilizing both centralized and decentralized resource models.Our Team partners with the business to optimize performance, compliance and engagement of our employees globally. We do this by providing effective systems, learning solutions and innovative opportunities for employee growth. The impact of our work drives greater intangible human capital assets to increase overall market value for AstraZeneca.

Educational Architect and Learning Strategist for Global Biologics Manufacturing Operations. Business Partner supporting Manufacturing, Tech Transfer, Quality Assurance, Quality Control, Validation and Facilities & Engineering Groups.Training Program Development per 21CFR, ICH Q10 (Analysis through Assessment), Learning Management System Business Process Owner.Strategic Workforce Planning and Talent Pipeline Development; Connecting Academia, Government and Industry entities to cultivate the next generation of scientists and engineers to support AZ R&D and Ops, world-wide.Learning & Development ecosystem building to drive lab/manufacturing-of-the future and workforce-of-the-future preparedness for the industry.

Laboratory Sciences Instructor. Biology, Molecular Biology, Research Methods.Full-load student advisor.Best practices in adult education and teaching methodologies. Behaviorism, Constructivism, 5E, SAM, ADDIE, Assessment and Effectiveness Measures.

Gene To Protein (G2P) Consulting, Inc. assists academic, government and private research laboratories with the design and outsource manufacturing of candidate biotherapeutics at the pre-clinical stage.

Designed and created expression systems for biologics in several species (phage, recombinant virus, VLPs, bacteria, yeast, insect, mammalian). Validation and expression optimization prior to large scale production and purification of candidate proteins. Specialized in recombinant virus production (adeno, adeno-associated, retro and lenti) and stable cell line development.

ES/Cell line development and neuro-transplantation studies in neuro-degenerative, -cognitive and -pathological models of disease.

Studied signal transduction pathways involved in the pathology of HIV-associated dementia.